Serveur d'exploration sur l'Université de Trèves

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa

Identifieur interne : 001218 ( Istex/Corpus ); précédent : 001217; suivant : 001219

Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa

Auteurs : Peter Neudeck ; Georg E. Jacoby ; Irmela Florin

Source :

RBID : ISTEX:76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A

English descriptors

Abstract

The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV; N=48) and healthy controls (N=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.

Url:
DOI: 10.1016/S0031-9384(00)00387-5

Links to Exploration step

ISTEX:76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
<author>
<name sortKey="Neudeck, Peter" sort="Neudeck, Peter" uniqKey="Neudeck P" first="Peter" last="Neudeck">Peter Neudeck</name>
<affiliation>
<mods:affiliation>E-mail: cds_berlin@t-online.de</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jacoby, Georg E" sort="Jacoby, Georg E" uniqKey="Jacoby G" first="Georg E" last="Jacoby">Georg E. Jacoby</name>
<affiliation>
<mods:affiliation>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Florin, Irmela" sort="Florin, Irmela" uniqKey="Florin I" first="Irmela" last="Florin">Irmela Florin</name>
<affiliation>
<mods:affiliation>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0031-9384(00)00387-5</idno>
<idno type="url">https://api.istex.fr/document/76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001218</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001218</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
<author>
<name sortKey="Neudeck, Peter" sort="Neudeck, Peter" uniqKey="Neudeck P" first="Peter" last="Neudeck">Peter Neudeck</name>
<affiliation>
<mods:affiliation>E-mail: cds_berlin@t-online.de</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jacoby, Georg E" sort="Jacoby, Georg E" uniqKey="Jacoby G" first="Georg E" last="Jacoby">Georg E. Jacoby</name>
<affiliation>
<mods:affiliation>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Florin, Irmela" sort="Florin, Irmela" uniqKey="Florin I" first="Irmela" last="Florin">Irmela Florin</name>
<affiliation>
<mods:affiliation>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Physiology & Behavior</title>
<title level="j" type="abbrev">PHB</title>
<idno type="ISSN">0031-9384</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">72</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="93">93</biblScope>
<biblScope unit="page" to="98">98</biblScope>
</imprint>
<idno type="ISSN">0031-9384</idno>
</series>
<idno type="istex">76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A</idno>
<idno type="DOI">10.1016/S0031-9384(00)00387-5</idno>
<idno type="PII">S0031-9384(00)00387-5</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0031-9384</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Bulimia</term>
<term>Dexamethasone suppression test</term>
<term>Salivary cortisol</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV; N=48) and healthy controls (N=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>Peter Neudeck</name>
<affiliations>
<json:string>E-mail: cds_berlin@t-online.de</json:string>
<json:string>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Georg E Jacoby</name>
<affiliations>
<json:string>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Irmela Florin</name>
<affiliations>
<json:string>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Dexamethasone suppression test</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Bulimia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Salivary cortisol</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<abstract>The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV; N=48) and healthy controls (N=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.</abstract>
<qualityIndicators>
<score>6.228</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>594 x 792 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>3</keywordCount>
<abstractCharCount>1411</abstractCharCount>
<pdfWordCount>3792</pdfWordCount>
<pdfCharCount>23019</pdfCharCount>
<pdfPageCount>6</pdfPageCount>
<abstractWordCount>203</abstractWordCount>
</qualityIndicators>
<title>Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
<pii>
<json:string>S0031-9384(00)00387-5</json:string>
</pii>
<refBibs>
<json:item>
<author>
<json:item>
<name>JI Hudson</name>
</json:item>
<json:item>
<name>PS Laffer</name>
</json:item>
<json:item>
<name>HG Pope</name>
</json:item>
</author>
<host>
<volume>135</volume>
<pages>
<last>687</last>
<first>685</first>
</pages>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>Bulimia related to affective disorder by family history and response to the dexamethasone-suppression-test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JE Mitchell</name>
</json:item>
<json:item>
<name>JP Bantle</name>
</json:item>
</author>
<host>
<volume>18</volume>
<pages>
<last>365</last>
<first>355</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>Metabolic and endocrine investigations in women with the bulimia syndrome</title>
</json:item>
<json:item>
<author>
<json:item>
<name>EL Perez</name>
</json:item>
<json:item>
<name>J Blouin</name>
</json:item>
<json:item>
<name>A Blouin</name>
</json:item>
</author>
<host>
<volume>49</volume>
<pages>
<last>97</last>
<first>94</first>
</pages>
<author></author>
<title>J Clin Psychiatry</title>
</host>
<title>The dexamethasone suppression test in bulimia: nonsuppression associated with depression and sub-optimal weight</title>
</json:item>
<json:item>
<author>
<json:item>
<name>MM Fichter</name>
</json:item>
<json:item>
<name>KM Pirke</name>
</json:item>
<json:item>
<name>J Pöllinger</name>
</json:item>
<json:item>
<name>G Wolfram</name>
</json:item>
<json:item>
<name>E Brunner</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>1037</last>
<first>1021</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>AH Rosenbaum</name>
</json:item>
<json:item>
<name>AF Schatzberg</name>
</json:item>
<json:item>
<name>RA MacLaughlin</name>
</json:item>
<json:item>
<name>K Snyder</name>
</json:item>
<json:item>
<name>NS Jiang</name>
</json:item>
<json:item>
<name>D Ilstrup</name>
</json:item>
</author>
<host>
<volume>141</volume>
<pages>
<last>1555</last>
<first>1550</first>
</pages>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Zimmerman</name>
</json:item>
<json:item>
<name>W Coryell</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>251</last>
<first>245</first>
</pages>
<author></author>
<title>Psychoneuroendocrinology</title>
</host>
<title>The dexamethasone suppression test in healthy controls</title>
</json:item>
<json:item>
<author>
<json:item>
<name>N Cook</name>
</json:item>
<json:item>
<name>B Harris</name>
</json:item>
<json:item>
<name>R Walker</name>
</json:item>
<json:item>
<name>R Hailwood</name>
</json:item>
<json:item>
<name>E Jones</name>
</json:item>
<json:item>
<name>S Johns</name>
</json:item>
</author>
<host>
<volume>18</volume>
<pages>
<last>150</last>
<first>143</first>
</pages>
<author></author>
<title>Psychiatry Res</title>
</host>
<title>Clinical utility of the dexamethasone suppression test assessed by plasma and salivary cortisol determinations</title>
</json:item>
<json:item>
<author>
<json:item>
<name>DM Garner</name>
</json:item>
<json:item>
<name>PE Garfinkel</name>
</json:item>
</author>
<host>
<volume>9</volume>
<pages>
<last>279</last>
<first>273</first>
</pages>
<author></author>
<title>Psychol Med</title>
</host>
<title>The Eating Attitudes Test: an index of the symptoms of anorexia nervosa</title>
</json:item>
<json:item>
<author>
<json:item>
<name>CK Edelstein</name>
</json:item>
<json:item>
<name>P Roy-Byrne</name>
</json:item>
<json:item>
<name>FI Fawzy</name>
</json:item>
<json:item>
<name>L Dornfeld</name>
</json:item>
</author>
<host>
<volume>140</volume>
<pages>
<last>341</last>
<first>338</first>
</pages>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>Effects of weight loss on the dexamethasone suppression test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>BT Walsh</name>
</json:item>
<json:item>
<name>SP Roose</name>
</json:item>
<json:item>
<name>JL Katz</name>
</json:item>
<json:item>
<name>I Dryenfurth</name>
</json:item>
<json:item>
<name>L Wright</name>
</json:item>
<json:item>
<name>R Vande Wiele</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>140</last>
<first>131</first>
</pages>
<author></author>
<title>Psychoneuroendocrinology</title>
</host>
<title>Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G O'Brien</name>
</json:item>
<json:item>
<name>A Hassanyeh</name>
</json:item>
<json:item>
<name>A Leake</name>
</json:item>
<json:item>
<name>K Schapira</name>
</json:item>
<json:item>
<name>M White</name>
</json:item>
<json:item>
<name>IN Ferrier</name>
</json:item>
</author>
<host>
<volume>152</volume>
<pages>
<last>556</last>
<first>554</first>
</pages>
<author></author>
<title>Br J Psychiatry</title>
</host>
<title>The dexamethasone suppression test in bulimia nervosa</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Bailly</name>
</json:item>
<json:item>
<name>N Regnaut</name>
</json:item>
<json:item>
<name>PJ Parquet</name>
</json:item>
</author>
<host>
<volume>7</volume>
<pages>
<last>89</last>
<first>85</first>
</pages>
<author></author>
<title>Eur Psychiatry</title>
</host>
<title>The dexamethasone suppression test in bulimic outpatients without major depression</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Ansseau</name>
</json:item>
<json:item>
<name>J Sulon</name>
</json:item>
<json:item>
<name>A Doumont</name>
</json:item>
<json:item>
<name>JL Cerfontaine</name>
</json:item>
<json:item>
<name>JJ Legros</name>
</json:item>
<json:item>
<name>JC Sodoyez</name>
</json:item>
<json:item>
<name>E Demey-Ponsart</name>
</json:item>
</author>
<host>
<volume>13</volume>
<pages>
<last>211</last>
<first>203</first>
</pages>
<author></author>
<title>Psychiatry Res</title>
</host>
<title>Use of saliva cortisol in the dexamethasone suppression test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Harris</name>
</json:item>
<json:item>
<name>S Watkins</name>
</json:item>
<json:item>
<name>N Cook</name>
</json:item>
<json:item>
<name>RF Walker</name>
</json:item>
<json:item>
<name>G Read</name>
</json:item>
<json:item>
<name>D Riad-Fahmy</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>904</last>
<first>897</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>Comparisons of plasma and salivary cortisol determinations for the diagnostic efficacy of the dexamethasone suppression test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R Garlard</name>
</json:item>
<json:item>
<name>GM Gallart</name>
</json:item>
<json:item>
<name>R Catalan</name>
</json:item>
<json:item>
<name>S Schwartz</name>
</json:item>
<json:item>
<name>JM Arguello</name>
</json:item>
<json:item>
<name>JM Castellanos</name>
</json:item>
</author>
<host>
<volume>148</volume>
<pages>
<last>508</last>
<first>504</first>
</pages>
<issue>4</issue>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Berger</name>
</json:item>
<json:item>
<name>KM Pirke</name>
</json:item>
<json:item>
<name>P Doerr</name>
</json:item>
<json:item>
<name>JC Krieg</name>
</json:item>
<json:item>
<name>D von Zerssen</name>
</json:item>
</author>
<host>
<volume>145</volume>
<pages>
<last>382</last>
<first>372</first>
</pages>
<author></author>
<title>Br J Psychiatry</title>
</host>
<title>The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry</title>
</json:item>
<json:item>
<author>
<json:item>
<name>MM Fichter</name>
</json:item>
<json:item>
<name>KM Pirke</name>
</json:item>
<json:item>
<name>F Holsboer</name>
</json:item>
</author>
<host>
<volume>17</volume>
<pages>
<last>72</last>
<first>61</first>
</pages>
<author></author>
<title>Psychiatry Res</title>
</host>
<title>Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F Holsboer</name>
</json:item>
</author>
<host>
<volume>238</volume>
<pages>
<last>322</last>
<first>302</first>
</pages>
<author></author>
<title>Eur Arch Psychiatry Neurol Sci</title>
</host>
<title>Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity</title>
</json:item>
<json:item>
<author>
<json:item>
<name>BT O'Sullivan</name>
</json:item>
<json:item>
<name>GE Hunt</name>
</json:item>
<json:item>
<name>GF Johnson</name>
</json:item>
<json:item>
<name>ID Caterson</name>
</json:item>
</author>
<host>
<volume>25</volume>
<pages>
<last>754</last>
<first>739</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Diagnostic and statistical manual of mental disorders (DSM IV)</title>
</host>
</json:item>
<json:item>
<host>
<author></author>
<title>DIPS. Diagnostisches Interview bei psychischen Störungen. Handbuch</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>RA Dressendörfer</name>
</json:item>
<json:item>
<name>C Kirschbaum</name>
</json:item>
<json:item>
<name>W Rohde</name>
</json:item>
<json:item>
<name>F Stahl</name>
</json:item>
<json:item>
<name>CJ Strassburger</name>
</json:item>
</author>
<host>
<volume>43</volume>
<pages>
<last>692</last>
<first>683</first>
</pages>
<author></author>
<title>J Steroid Biochem Mol Biol</title>
</host>
<title>Synthesis of a cortisol–biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Fragebogen zu Kompetenz- und Kontrollüberzeugungen (FKK)</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>AT Beck</name>
</json:item>
<json:item>
<name>CH Ward</name>
</json:item>
<json:item>
<name>M Mendelsohn</name>
</json:item>
<json:item>
<name>J Mock</name>
</json:item>
<json:item>
<name>J Erbaugh</name>
</json:item>
</author>
<host>
<volume>4</volume>
<pages>
<last>571</last>
<first>561</first>
</pages>
<author></author>
<title>Arch Gen Psychiatry</title>
</host>
<title>An inventory for measuring depression</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Das Beck-Depressions-Inventar</title>
</host>
</json:item>
<json:item>
<host>
<author></author>
<title>Fragebogen zum Eßverhalten (FEV)</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>DC Lindy</name>
</json:item>
<json:item>
<name>BT Walsh</name>
</json:item>
<json:item>
<name>SP Roose</name>
</json:item>
<json:item>
<name>M Gladis</name>
</json:item>
<json:item>
<name>AH Glassman</name>
</json:item>
</author>
<host>
<volume>142</volume>
<pages>
<last>1376</last>
<first>1375</first>
</pages>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>The dexamethasone suppression test in bulimia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>HE Gwirtsman</name>
</json:item>
<json:item>
<name>P Roy-Byrne</name>
</json:item>
<json:item>
<name>J Yager</name>
</json:item>
<json:item>
<name>RH Gerner</name>
</json:item>
</author>
<host>
<volume>140</volume>
<pages>
<last>563</last>
<first>559</first>
</pages>
<author></author>
<title>Am J Psychiatry</title>
</host>
<title>Neuroendocrine abnormalities in bulimia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>WH Kaye</name>
</json:item>
<json:item>
<name>HE Gwirtsman</name>
</json:item>
<json:item>
<name>DT George</name>
</json:item>
</author>
<host>
<volume>25</volume>
<pages>
<last>780</last>
<first>768</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>The effect of bingeing and vomiting on hormonal secretion</title>
</json:item>
<json:item>
<author>
<json:item>
<name>K Wiedemann</name>
</json:item>
<json:item>
<name>F Holsboer</name>
</json:item>
</author>
<host>
<volume>19</volume>
<pages>
<last>137</last>
<first>133</first>
</pages>
<author></author>
<title>J Affective Disord</title>
</host>
<title>The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F Holsboer</name>
</json:item>
</author>
<host>
<volume>33</volume>
<pages>
<last>214</last>
<first>181</first>
</pages>
<author></author>
<title>J Psychiatr Res</title>
</host>
<title>The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonist to treat depression and anxiety</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Berger</name>
</json:item>
<json:item>
<name>KM Pirke</name>
</json:item>
<json:item>
<name>JC Krieg</name>
</json:item>
<json:item>
<name>D von Zerssen</name>
</json:item>
</author>
<host>
<volume>15</volume>
<pages>
<last>360</last>
<first>351</first>
</pages>
<author></author>
<title>Psychiatry Res</title>
</host>
<title>The effect of weight loss and inappropriate plasma dexamethasone levels on the DST</title>
</json:item>
<json:item>
<author>
<json:item>
<name>BT Walsh</name>
</json:item>
<json:item>
<name>ES Lo</name>
</json:item>
<json:item>
<name>T Cooper</name>
</json:item>
<json:item>
<name>DC Lindy</name>
</json:item>
<json:item>
<name>SP Roose</name>
</json:item>
<json:item>
<name>M Gladis</name>
</json:item>
</author>
<host>
<volume>44</volume>
<pages>
<last>800</last>
<first>797</first>
</pages>
<author></author>
<title>Arch Gen Psychiatry</title>
</host>
<title>Dexamethasone suppression test and plasma dexamethasone levels in bulimia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>S Fukata</name>
</json:item>
<json:item>
<name>H Tamai</name>
</json:item>
<json:item>
<name>Y Takaichi</name>
</json:item>
<json:item>
<name>S Matsubayashi</name>
</json:item>
<json:item>
<name>T Nakagawa</name>
</json:item>
</author>
<host>
<volume>42</volume>
<pages>
<last>64</last>
<first>59</first>
</pages>
<author></author>
<title>Jpn J Psychiatry Neurol</title>
</host>
<title>The dexamethasone suppression test for Japanese eating disorders</title>
</json:item>
<json:item>
<author>
<json:item>
<name>SF Leibowitz</name>
</json:item>
<json:item>
<name>JT Alexander</name>
</json:item>
</author>
<host>
<volume>44</volume>
<pages>
<last>864</last>
<first>851</first>
</pages>
<author></author>
<title>Biol Psychiatry</title>
</host>
<title>Hypothalamic serotonin in control of eating behavior, meal size and body weight</title>
</json:item>
<json:item>
<author>
<json:item>
<name>WH Yu</name>
</json:item>
<json:item>
<name>M Kimura</name>
</json:item>
<json:item>
<name>A Walczewska</name>
</json:item>
<json:item>
<name>S Karanth</name>
</json:item>
<json:item>
<name>SM Mc Cann</name>
</json:item>
</author>
<host>
<volume>94</volume>
<pages>
<last>1028</last>
<first>1023</first>
</pages>
<author></author>
<title>Proc Natl Acad Sci</title>
</host>
<title>Role of leptin in the hypothalamic-pituitary function</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JE Schneider</name>
</json:item>
<json:item>
<name>MD Goldman</name>
</json:item>
<json:item>
<name>S Tang</name>
</json:item>
<json:item>
<name>B Bean</name>
</json:item>
<json:item>
<name>MI Friedman</name>
</json:item>
</author>
<host>
<volume>33</volume>
<pages>
<last>228</last>
<first>217</first>
</pages>
<author></author>
<title>Horm Behav</title>
</host>
<title>Leptin indirectly affects estrous cycles by increasing metabolic fuel oxidation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>MP Warren</name>
</json:item>
<json:item>
<name>F Voussoughian</name>
</json:item>
<json:item>
<name>EB Geer</name>
</json:item>
<json:item>
<name>EP Hyle</name>
</json:item>
<json:item>
<name>CL Adberg</name>
</json:item>
<json:item>
<name>RH Ramos</name>
</json:item>
</author>
<host>
<volume>84</volume>
<pages>
<last>877</last>
<first>873</first>
</pages>
<author></author>
<title>J Clin Endocrinol Metab</title>
</host>
<title>Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating</title>
</json:item>
<json:item>
<author>
<json:item>
<name>PW Gold</name>
</json:item>
<json:item>
<name>H Gwirtsman</name>
</json:item>
<json:item>
<name>PC Averginos</name>
</json:item>
<json:item>
<name>LK Nieman</name>
</json:item>
<json:item>
<name>WT Galluci</name>
</json:item>
<json:item>
<name>W Kaye</name>
</json:item>
</author>
<host>
<volume>314</volume>
<pages>
<last>1342</last>
<first>1335</first>
</pages>
<author></author>
<title>N Engl J Med</title>
</host>
<title>Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysical mechanisms in underweight and weight corrected patients</title>
</json:item>
<json:item>
<author>
<json:item>
<name>RF Vining</name>
</json:item>
<json:item>
<name>RA McGinley</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>94</last>
<first>81</first>
</pages>
<author></author>
<title>J Steroid Biochem</title>
</host>
<title>The measurement of hormones in saliva: possibilities and pitfalls</title>
</json:item>
</refBibs>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>72</volume>
<pii>
<json:string>S0031-9384(00)X0072-8</json:string>
</pii>
<pages>
<last>98</last>
<first>93</first>
</pages>
<issn>
<json:string>0031-9384</json:string>
</issn>
<issue>1–2</issue>
<genre>
<json:string>journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Physiology & Behavior</title>
<publicationDate>2001</publicationDate>
</host>
<categories>
<wos>
<json:string>social science</json:string>
<json:string>psychology, biological</json:string>
<json:string>science</json:string>
<json:string>behavioral sciences</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>psychology & cognitive sciences</json:string>
<json:string>behavioral science & comparative psychology</json:string>
</scienceMetrix>
</categories>
<publicationDate>2001</publicationDate>
<copyrightDate>2001</copyrightDate>
<doi>
<json:string>10.1016/S0031-9384(00)00387-5</json:string>
</doi>
<id>76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A</id>
<score>0.024304172</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>©2001 Elsevier Science Inc.</p>
</availability>
<date>2001</date>
</publicationStmt>
<notesStmt>
<note>Statement of informed consent: We ensure that all subjects were informed about the aim of the study, especially about the use of dexamethasone. The experiment was authorized by the “Ethik Kommision” of the German Society of Psychology.</note>
<note type="content">Table 1: Cortisol levels in saliva (nmol/l) under basal conditions (means and S.D.)</note>
<note type="content">Table 2: Cortisol levels in saliva (nmol/l) after 1.5-mg DEX (means and S.D.)</note>
<note type="content">Table 3: Differences between bulimic suppressors and nonsuppressors for chosen variables</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
<author xml:id="author-1">
<persName>
<forename type="first">Peter</forename>
<surname>Neudeck</surname>
</persName>
<email>cds_berlin@t-online.de</email>
<note type="correspondence">
<p>Corresponding author. Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117 Berlin. Tel.: +49-30-25298473; fax: +49-0-30-25298470</p>
</note>
<affiliation>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</affiliation>
</author>
<author xml:id="author-2">
<persName>
<forename type="first">Georg E</forename>
<surname>Jacoby</surname>
</persName>
<affiliation>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">Irmela</forename>
<surname>Florin</surname>
</persName>
<note type="biography">Deceased in December 1998.</note>
<affiliation>Deceased in December 1998.</affiliation>
<affiliation>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Physiology & Behavior</title>
<title level="j" type="abbrev">PHB</title>
<idno type="pISSN">0031-9384</idno>
<idno type="PII">S0031-9384(00)X0072-8</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001"></date>
<biblScope unit="volume">72</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="93">93</biblScope>
<biblScope unit="page" to="98">98</biblScope>
</imprint>
</monogr>
<idno type="istex">76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A</idno>
<idno type="DOI">10.1016/S0031-9384(00)00387-5</idno>
<idno type="PII">S0031-9384(00)00387-5</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2001</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV; N=48) and healthy controls (N=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Dexamethasone suppression test</term>
</item>
<item>
<term>Bulimia</term>
</item>
<item>
<term>Salivary cortisol</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2000-06-09">Modified</change>
<change when="2001">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla" xml:lang="en">
<item-info>
<jid>PHB</jid>
<aid>6231</aid>
<ce:pii>S0031-9384(00)00387-5</ce:pii>
<ce:doi>10.1016/S0031-9384(00)00387-5</ce:doi>
<ce:copyright type="full-transfer" year="2001">Elsevier Science Inc.</ce:copyright>
</item-info>
<head>
<ce:article-footnote>
<ce:label></ce:label>
<ce:note-para>Statement of informed consent: We ensure that all subjects were informed about the aim of the study, especially about the use of dexamethasone. The experiment was authorized by the “Ethik Kommision” of the German Society of Psychology.</ce:note-para>
</ce:article-footnote>
<ce:title>Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>Peter</ce:given-name>
<ce:surname>Neudeck</ce:surname>
<ce:cross-ref refid="AFF1">
<ce:sup>a</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="CORR1">*</ce:cross-ref>
<ce:e-address>cds_berlin@t-online.de</ce:e-address>
</ce:author>
<ce:author>
<ce:given-name>Georg E</ce:given-name>
<ce:surname>Jacoby</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Irmela</ce:given-name>
<ce:surname>Florin</ce:surname>
<ce:cross-ref refid="FN1">
<ce:sup>1</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF3">
<ce:sup>c</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF3">
<ce:label>c</ce:label>
<ce:textfn>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</ce:textfn>
</ce:affiliation>
<ce:correspondence id="CORR1">
<ce:label>*</ce:label>
<ce:text>Corresponding author. Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117 Berlin. Tel.: +49-30-25298473; fax: +49-0-30-25298470</ce:text>
</ce:correspondence>
<ce:footnote id="FN1">
<ce:label>1</ce:label>
<ce:note-para>Deceased in December 1998.</ce:note-para>
</ce:footnote>
</ce:author-group>
<ce:date-received day="11" month="4" year="2000"></ce:date-received>
<ce:date-revised day="9" month="6" year="2000"></ce:date-revised>
<ce:date-accepted day="25" month="8" year="2000"></ce:date-accepted>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV;
<ce:italic>N</ce:italic>
=48) and healthy controls (
<ce:italic>N</ce:italic>
=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
<ce:keywords class="keyword">
<ce:section-title>Keywords</ce:section-title>
<ce:keyword>
<ce:text>Dexamethasone suppression test</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Bulimia</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>Salivary cortisol</ce:text>
</ce:keyword>
</ce:keywords>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa</title>
</titleInfo>
<name type="personal">
<namePart type="given">Peter</namePart>
<namePart type="family">Neudeck</namePart>
<affiliation>E-mail: cds_berlin@t-online.de</affiliation>
<affiliation>Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117, Berlin, Germany</affiliation>
<description>Corresponding author. Christoph-Dornier Foundation for Clinical Psychology, Marienstraße 18, D-10117 Berlin. Tel.: +49-30-25298473; fax: +49-0-30-25298470</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Georg E</namePart>
<namePart type="family">Jacoby</namePart>
<affiliation>Klinik am Korso, Ostkorso 4, 32545 Bad Oeynhausen, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Irmela</namePart>
<namePart type="family">Florin</namePart>
<affiliation>Department of Psychology, Philipps University Marburg, Gutenbergstrasse 5, 35032 Marburg, Germany</affiliation>
<description>Deceased in December 1998.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">2001</dateIssued>
<dateModified encoding="w3cdtf">2000-06-09</dateModified>
<copyrightDate encoding="w3cdtf">2001</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">The assessment of cortisol in saliva has been proven a valid and reliable reflection of the respective unbound hormone in blood. In the present study, a standard dexamethasone suppression test (DST) with measures of salivary cortisol levels was performed in bulimic women without depression (DSM-IV; N=48) and healthy controls (N=24) matched for age. Feedback sensitivity was assessed using the standard DST with pre- and post-measures of salivary cortisol. Subjects were divided into suppressors and nonsuppressors according to their post-DST levels. Bulimic suppressors and nonsuppressors were compared for their basal cortisol levels, body weight (body mass index, BMI), previous episodes of anorexia nervosa, and their results in psychometric tests. A total of 16 (33.3%) out of 48 women with bulimia nervosa (BN) failed to suppress in the DST. Basal salivary cortisol levels were elevated in bulimic nonsuppressors. Significant differences between suppressors and nonsuppressors were found for body weight and previous episodes of anorexia nervosa. The results are in accordance with recent findings. They support the hypothesized association between low body weight and DST nonsuppression. Using saliva cortisol in the standard DST could be advantageous for studying bulimic patients. Furthermore, the results show the importance of determining HPA reagibility when measuring cortisol in bulimic patients.</abstract>
<note>Statement of informed consent: We ensure that all subjects were informed about the aim of the study, especially about the use of dexamethasone. The experiment was authorized by the “Ethik Kommision” of the German Society of Psychology.</note>
<note type="content">Table 1: Cortisol levels in saliva (nmol/l) under basal conditions (means and S.D.)</note>
<note type="content">Table 2: Cortisol levels in saliva (nmol/l) after 1.5-mg DEX (means and S.D.)</note>
<note type="content">Table 3: Differences between bulimic suppressors and nonsuppressors for chosen variables</note>
<subject lang="en">
<genre>Keywords</genre>
<topic>Dexamethasone suppression test</topic>
<topic>Bulimia</topic>
<topic>Salivary cortisol</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Physiology & Behavior</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>PHB</title>
</titleInfo>
<genre type="journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">200101</dateIssued>
</originInfo>
<identifier type="ISSN">0031-9384</identifier>
<identifier type="PII">S0031-9384(00)X0072-8</identifier>
<part>
<date>200101</date>
<detail type="volume">
<number>72</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>1–2</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>1</start>
<end>290</end>
</extent>
<extent unit="pages">
<start>93</start>
<end>98</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A</identifier>
<identifier type="DOI">10.1016/S0031-9384(00)00387-5</identifier>
<identifier type="PII">S0031-9384(00)00387-5</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©2001 Elsevier Science Inc.</accessCondition>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
<recordOrigin>Elsevier Science Inc., ©2001</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001218 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001218 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:76B8CF98657BB6A8F3448AD2A46CEDADDCA06B0A
   |texte=   Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024